Sonoma Pharmaceuticals (SNOA) Inventory Average (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Inventory Average of $3.7 million for Q1 2026, up 15.7% year-over-year from $3.2 million in Q1 2025, and little changed quarter-over-quarter from $3.7 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Inventory Average (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Inventory Average rose 15.7% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 15.7% YoY), while the FY2026 annual figure was $3.4 million, up 10.21% from the prior year.
- Inventory Average for Q1 2026 stood at $3.7 million, roughly flat from $3.7 million in the prior quarter.
- The five-year high for Inventory Average was $3.7 million in Q3 2025, with the low at $2.6 million in Q3 2023.
- The 5-year median for Inventory Average is $3.0 million (2024), against an average of $3.1 million.
- The sharpest annual moves came in 2023 and 2025: Inventory Average declined 9.81% in 2023, then gained 23.71% in 2025.
- Sonoma Pharmaceuticals' Inventory Average stood at $2.9 million in 2022, then dropped by 6.91% to $2.7 million in 2023, then advanced by 14.01% to $3.1 million in 2024, then grew by 17.69% to $3.7 million in 2025, then grew by 0.23% to $3.7 million in 2026.
- Business Quant data shows SNOA's Inventory Average at $3.7 million in Q1 2026, $3.7 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.34 Mn |
| Mar 31, 2026 | 3.68 Mn |
| Dec 31, 2025 | 3.67 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.79 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.55 Mn |